To explore how RBM10C761Y modulated ASPM203 and enhanced CCA development in a β-catenin signaling dependent manner, we investigated the effect of ASPM203 silencing and DVL2 upregulation on CCA cell proliferation in two cell lines. The gene discussed is DVL2; the disease is cholangiocarcinoma.